Greenland Mines (GRML)
Market Price (10/29/2026): $5.4 | Market Cap: $73.9 MilSector: Materials | Industry: Precious Metals & Minerals
Greenland Mines (GRML)
Market Price (10/29/2026): $5.4Market Cap: $73.9 MilSector: MaterialsIndustry: Precious Metals & Minerals
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -66% Megatrend and thematic driversMegatrends include Battery Technology & Metals. Themes include Rare Earth Elements. | Very low revenueRev LTMTotal Revenue or Sales, Last Twelve Months is 0 Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -18 Mil Stock price has recently run up significantly6M Rtn6 month market price return is 1173%, 12M Rtn12 month market price return is 1065% Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -176% High stock price volatilityVol 12M is 8529% Significant short interestShort Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 122% |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -66% |
| Megatrend and thematic driversMegatrends include Battery Technology & Metals. Themes include Rare Earth Elements. |
| Very low revenueRev LTMTotal Revenue or Sales, Last Twelve Months is 0 |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -18 Mil |
| Stock price has recently run up significantly6M Rtn6 month market price return is 1173%, 12M Rtn12 month market price return is 1065% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -176% |
| High stock price volatilityVol 12M is 8529% |
| Significant short interestShort Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 122% |
Qualitative Assessment
AI Analysis | Feedback
Updated on 10/24/2026
Greenland Mines (GRML) stock has lost about 60% since 6/30/2026 because of the following key factors:
1. Strategic Acquisitions and Significant Resource Upgrades. Greenland Mines completed the acquisition of the Sarfartoq Neodymium-Praseodymium rare earths project on September 1, 2026 (fiscal Q3 2026). An Initial Assessment for Sarfartoq projected a high-case pre-tax Net Present Value of approximately US$2.05 billion and an internal rate of return of 118.6% over nine years. Additionally, the Skaergaard Project's S-K 1300 Mineral Resource Estimate, effective July 3, 2026 (fiscal Q3 2026), reported 15.0 million ounces of palladium equivalent (PdEq) in the Indicated category, representing a 31% increase in contained Indicated PdEq metal and a 36% increase in Indicated grade compared to the prior 2022 estimate. The Skaergaard project's total in-situ gross metal value was estimated above $69 billion.
2. Geopolitical Tailwinds and Strategic Partnerships for Critical Minerals. A landmark U.S.-Denmark-Greenland security agreement, announced around September 21, 2026 (fiscal Q3 2026), enhanced the strategic importance of Greenland's critical mineral assets by expanding U.S. military presence and restricting non-allied investment, directly benefiting companies like Greenland Mines. Furthermore, in fiscal Q3 2026, Greenland Mines welcomed Neo Performance Materials as a strategic shareholder, securing offtake rights for up to 60% of Sarfartoq's future rare earth production for its Estonian separation facility, thereby reinforcing Western supply chains.
Show more
Greenland Mines (GRML) stock has lost about 60% since 6/30/2026 because of the following key factors:
1. Strategic Acquisitions and Significant Resource Upgrades. Greenland Mines completed the acquisition of the Sarfartoq Neodymium-Praseodymium rare earths project on September 1, 2026 (fiscal Q3 2026). An Initial Assessment for Sarfartoq projected a high-case pre-tax Net Present Value of approximately US$2.05 billion and an internal rate of return of 118.6% over nine years. Additionally, the Skaergaard Project's S-K 1300 Mineral Resource Estimate, effective July 3, 2026 (fiscal Q3 2026), reported 15.0 million ounces of palladium equivalent (PdEq) in the Indicated category, representing a 31% increase in contained Indicated PdEq metal and a 36% increase in Indicated grade compared to the prior 2022 estimate. The Skaergaard project's total in-situ gross metal value was estimated above $69 billion.
2. Geopolitical Tailwinds and Strategic Partnerships for Critical Minerals. A landmark U.S.-Denmark-Greenland security agreement, announced around September 21, 2026 (fiscal Q3 2026), enhanced the strategic importance of Greenland's critical mineral assets by expanding U.S. military presence and restricting non-allied investment, directly benefiting companies like Greenland Mines. Furthermore, in fiscal Q3 2026, Greenland Mines welcomed Neo Performance Materials as a strategic shareholder, securing offtake rights for up to 60% of Sarfartoq's future rare earth production for its Estonian separation facility, thereby reinforcing Western supply chains.
Show more
Updated on 10/24/2026
Greenland Mines (GRML) stock has lost about 60% since 6/30/2026 because of the following key factors:
1. Strategic Acquisitions and Significant Resource Upgrades. Greenland Mines completed the acquisition of the Sarfartoq Neodymium-Praseodymium rare earths project on September 1, 2026 (fiscal Q3 2026). An Initial Assessment for Sarfartoq projected a high-case pre-tax Net Present Value of approximately US$2.05 billion and an internal rate of return of 118.6% over nine years. Additionally, the Skaergaard Project's S-K 1300 Mineral Resource Estimate, effective July 3, 2026 (fiscal Q3 2026), reported 15.0 million ounces of palladium equivalent (PdEq) in the Indicated category, representing a 31% increase in contained Indicated PdEq metal and a 36% increase in Indicated grade compared to the prior 2022 estimate. The Skaergaard project's total in-situ gross metal value was estimated above $69 billion.
2. Geopolitical Tailwinds and Strategic Partnerships for Critical Minerals. A landmark U.S.-Denmark-Greenland security agreement, announced around September 21, 2026 (fiscal Q3 2026), enhanced the strategic importance of Greenland's critical mineral assets by expanding U.S. military presence and restricting non-allied investment, directly benefiting companies like Greenland Mines. Furthermore, in fiscal Q3 2026, Greenland Mines welcomed Neo Performance Materials as a strategic shareholder, securing offtake rights for up to 60% of Sarfartoq's future rare earth production for its Estonian separation facility, thereby reinforcing Western supply chains.
3. Substantial Capital Injection. Greenland Mines successfully raised over $59 million in new capital during fiscal Q3 2026. This included a registered direct offering around September 24, 2026, which secured over $42 million at $12 per share, and an additional $17.2 million from institutional investors through another registered direct offering around September 29, 2026. This significant financing is expected to fully fund the company's planned exploration and development programs through 2027.
Show less
Greenland Mines (GRML) stock has lost about 60% since 6/30/2026 because of the following key factors:
1. Strategic Acquisitions and Significant Resource Upgrades. Greenland Mines completed the acquisition of the Sarfartoq Neodymium-Praseodymium rare earths project on September 1, 2026 (fiscal Q3 2026). An Initial Assessment for Sarfartoq projected a high-case pre-tax Net Present Value of approximately US$2.05 billion and an internal rate of return of 118.6% over nine years. Additionally, the Skaergaard Project's S-K 1300 Mineral Resource Estimate, effective July 3, 2026 (fiscal Q3 2026), reported 15.0 million ounces of palladium equivalent (PdEq) in the Indicated category, representing a 31% increase in contained Indicated PdEq metal and a 36% increase in Indicated grade compared to the prior 2022 estimate. The Skaergaard project's total in-situ gross metal value was estimated above $69 billion.
2. Geopolitical Tailwinds and Strategic Partnerships for Critical Minerals. A landmark U.S.-Denmark-Greenland security agreement, announced around September 21, 2026 (fiscal Q3 2026), enhanced the strategic importance of Greenland's critical mineral assets by expanding U.S. military presence and restricting non-allied investment, directly benefiting companies like Greenland Mines. Furthermore, in fiscal Q3 2026, Greenland Mines welcomed Neo Performance Materials as a strategic shareholder, securing offtake rights for up to 60% of Sarfartoq's future rare earth production for its Estonian separation facility, thereby reinforcing Western supply chains.
3. Substantial Capital Injection. Greenland Mines successfully raised over $59 million in new capital during fiscal Q3 2026. This included a registered direct offering around September 24, 2026, which secured over $42 million at $12 per share, and an additional $17.2 million from institutional investors through another registered direct offering around September 29, 2026. This significant financing is expected to fully fund the company's planned exploration and development programs through 2027.
Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →
Stock Movement Drivers
Fundamental Drivers
The -58.1% change in GRML stock from 6/30/2026 to 10/28/2026 was primarily driven by a -22.7% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 6302026 | 10282026 | Change |
|---|---|---|---|
| Stock Price ($) | 13.00 | 5.45 | -58.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | � | � | 0.0% |
| Net Income Margin (%) | � | � | 0.0% |
| P/E Multiple | � | � | 0.0% |
| Shares Outstanding (Mil) | 2 | 2 | -22.7% |
| Cumulative Contribution | 0.0% |
Market Drivers
6/30/2026 to 10/28/2026| Return | Correlation | |
|---|---|---|
| GRML | -58.1% | |
| Market (SPY) | 3.4% | 3.5% |
| Sector (XLB) | 2.0% | 20.0% |
Fundamental Drivers
nullnull
Market Drivers
3/31/2026 to 10/28/2026| Return | Correlation | |
|---|---|---|
| GRML | -67.0% | |
| Market (SPY) | 19.1% | 4.9% |
| Sector (XLB) | 4.2% | 15.7% |
Fundamental Drivers
nullnull
Market Drivers
9/30/2025 to 10/28/2026| Return | Correlation | |
|---|---|---|
| GRML | -77.5% | |
| Market (SPY) | 16.9% | 7.1% |
| Sector (XLB) | 17.3% | 13.0% |
Fundamental Drivers
nullnull
Market Drivers
9/30/2023 to 10/28/2026| Return | Correlation | |
|---|---|---|
| GRML | -99.0% | |
| Market (SPY) | 86.9% | 4.5% |
| Sector (XLB) | 39.2% | 7.2% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| GRML Return | - | - | - | - | - | 1118% | 1118% |
| Peers Return | 26% | -8% | -14% | -5% | 8068% | -10% | 6854% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 13% | 106% |
Monthly Win Rates [3] | |||||||
| GRML Win Rate | - | - | - | - | - | 50% | |
| Peers Win Rate | 35% | 47% | 37% | 38% | 65% | 40% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| GRML Max Drawdown | - | - | - | - | - | - | |
| Peers Max Drawdown | -35% | -42% | -36% | -35% | -42% | -52% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: PLG, MP, USAR, NEM, GOLD.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 10/28/2026 (YTD)
How Low Can It Go
GRML has limited trading history. Below is the Materials sector ETF (XLB) in its place.
| Event | XLB | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -17.0% | -18.8% |
| % Gain to Breakeven | 20.5% | 23.1% |
| Time to Breakeven | 84 days | 79 days |
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -12.5% | -9.5% |
| % Gain to Breakeven | 14.3% | 10.5% |
| Time to Breakeven | 52 days | 24 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -23.5% | -24.5% |
| % Gain to Breakeven | 30.7% | 32.4% |
| Time to Breakeven | 456 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -36.2% | -33.7% |
| % Gain to Breakeven | 56.8% | 50.9% |
| Time to Breakeven | 114 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -18.3% | -19.2% |
| % Gain to Breakeven | 22.4% | 23.8% |
| Time to Breakeven | 101 days | 105 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -17.9% | -12.2% |
| % Gain to Breakeven | 21.7% | 13.9% |
| Time to Breakeven | 52 days | 62 days |
In The Past
State Street Materials Select Sector SPDR ETF's stock fell -17.0% during the 2025 US Tariff Shock. Such a loss loss requires a 20.5% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
GRML has limited trading history. Below is the Materials sector ETF (XLB) in its place.
| Event | XLB | S&P 500 |
|---|---|---|
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -23.5% | -24.5% |
| % Gain to Breakeven | 30.7% | 32.4% |
| Time to Breakeven | 456 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -36.2% | -33.7% |
| % Gain to Breakeven | 56.8% | 50.9% |
| Time to Breakeven | 114 days | 140 days |
| 2014-2016 Oil Price Collapse | ||
| % Loss | -23.8% | -6.8% |
| % Gain to Breakeven | 31.2% | 7.3% |
| Time to Breakeven | 171 days | 15 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -28.2% | -17.9% |
| % Gain to Breakeven | 39.3% | 21.8% |
| Time to Breakeven | 459 days | 123 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -56.6% | -53.4% |
| % Gain to Breakeven | 130.3% | 114.4% |
| Time to Breakeven | 701 days | 1085 days |
In The Past
State Street Materials Select Sector SPDR ETF's stock fell -17.0% during the 2025 US Tariff Shock. Such a loss loss requires a 20.5% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Greenland Mines (GRML)
Greenland Mines (GRML), operating as Klotho Neurosciences, Inc., is a biopharmaceutical company dedicated to developing innovative therapies and specialty diagnostics. Its core focus is on addressing neurological and age-related disorders, with a mission to mitigate severe conditions such as dementia symptoms, Alzheimer's disease, and various neuromuscular diseases.
The company's product portfolio is diverse, featuring advanced cell and gene therapies aimed at enhancing longevity and reducing age-related pathologies. Additionally, GRML develops biologics and biosimilars primarily for the treatment of cancer, alongside research into melanocortin receptors. A significant aspect of its research and development involves a strategic partnership with Japan's Okinawa Research Center, specifically for Klotho gene therapy focused on extending longevity and combating age-related illnesses.
Greenland Mines (GRML) primarily serves patient populations affected by neurological and age-related disorders, as well as individuals undergoing cancer treatment. Its efforts position the company within critical healthcare markets focused on improving quality of life and extending healthy lifespans through cutting-edge biomedical solutions.
AI Analysis | Feedback
null
AI Analysis | Feedback
null
AI Analysis | Feedback
null
AI Analysis | Feedback
null
AI Analysis | Feedback
null
AI Analysis | Feedback
null
AI Analysis | Feedback
null
AI Analysis | Feedback
Greenland Mines Ltd. (GRML) operates in two primary sectors: mineral exploration and development, and biotechnology. The company's main products and services include precious metals (palladium, gold, and platinum) and rare earth elements (neodymium and praseodymium) from its mining operations, as well as essential medicines for chronic diseases, including a generic drug portfolio, biosimilar biologics for cancer treatment, and gene therapies for neurodegenerative disorders, which involve the Klotho protein.
The addressable markets for Greenland Mines' products and services are substantial:
- Precious Metals (Palladium, Gold, Platinum): The company's Skaergaard Project in Southeast Greenland holds significant resources, with an estimated gross undiscounted in-situ metal value of approximately $68 billion based on February 2026 metal prices. While this represents resource value rather than an annual market, it indicates the scale of the underlying commodity markets. Globally, the precious metals market is extensive.
- Rare Earth Elements (Neodymium, Praseodymium): Greenland Mines is expanding its critical minerals platform to include rare earths. The global rare earth elements market was valued at $10.19 billion in 2023 and is projected to reach $20.50 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.20%. This market includes vital components for electric vehicle motors, wind turbines, and advanced electronics.
- Cell and Gene Therapies for Neurodegenerative Disorders: Greenland Mines is involved in the development of gene therapies using the Klotho protein for neurodegenerative diseases like ALS. The global cell and gene therapy market was valued at $18.61 billion in 2023 and is expected to grow to $203.26 billion by 2033, demonstrating a CAGR of 26.6%. Specifically, the global market for Alzheimer's disease therapeutics was valued at $6.7 billion in 2023 and is projected to reach $17.8 billion by 2033, with a CAGR of 10.3%. The anti-aging products market, related to Klotho's longevity aspects, was valued at $14.05 billion in the U.S. in 2024 and is forecasted to reach $27.44 billion by 2033, with a CAGR of 8.0%. Globally, the anti-aging market is expected to surpass $421.4 billion in revenue by 2030, with an 8.1% CAGR.
- Biosimilars for Cancer Treatment: The company's biotechnology segment includes a biosimilar biologics platform for treating cancer. The global oncology biosimilars market size was valued at $4.49 billion in 2023 and is projected to grow to $28.31 billion by 2033, exhibiting a CAGR of 20.32%.
AI Analysis | Feedback
null
AI Analysis | Feedback
null
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 24.47 |
| Mkt Cap | 2.3 |
| Rev LTM | 13 |
| Op Inc LTM | -18 |
| FCF LTM | -16 |
| FCF 3Y Avg | -53 |
| CFO LTM | -15 |
| CFO 3Y Avg | -25 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 24.9% |
| Rev Chg 3Y Avg | 19.3% |
| Rev Chg Q | 52.1% |
| QoQ Delta Rev Chg LTM | 20.1% |
| Op Inc Chg LTM | 7.3% |
| Op Inc Chg 3Y Avg | 3.5% |
| Op Mgn LTM | -34.1% |
| Op Mgn 3Y Avg | -8.6% |
| QoQ Delta Op Mgn LTM | 16.9% |
| CFO/Rev LTM | -27.5% |
| CFO/Rev 3Y Avg | 10.9% |
| FCF/Rev LTM | -165.2% |
| FCF/Rev 3Y Avg | -51.9% |
Price Behavior
Price Behavior
| Market Price | $5.45 | |
| Market Cap ($ Bil) | 0.0 | |
| First Trading Date | 04/29/2022 | |
| Distance from 52W High | -69.4% | |
| 50 Days | 200 Days | |
| DMA Price | $6.28 | |
| DMA Trend | up | |
| Distance from DMA | -13.3% | |
| 3M | 1YR | |
| Volatility | 9,521.9% | 8,529.0% |
| Downside Capture | -68.97 | |
| Upside Capture | 1777.39 | |
| Correlation (S&P 500) | 7.2% |
GRML Betas & Captures as of 9/30/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 2.90 | 95.44 | 59.63 | 25.60 | -20.39 | 34.77 |
| Up Beta | -1.70 | -397.81 | -201.15 | -199.21 | 2.91 | -104.88 |
| Down Beta | 222.15 | 120.83 | 42.94 | 15.72 | -2.56 | 5.20 |
| Up Capture | -389% | 17558% | 10921% | 5386% | 2352% | 216% |
| Bmk +ve Days | 6 | 16 | 27 | 66 | 132 | 424 |
| Stock +ve Days | 6 | 9 | 14 | 40 | 44 | 44 |
| Down Capture | -2889% | -1268% | -515% | 10% | 61% | 35% |
| Bmk -ve Days | 16 | 26 | 37 | 60 | 120 | 328 |
| Stock -ve Days | 15 | 18 | 25 | 61 | 70 | 70 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with GRML | |
|---|---|---|---|---|
| GRML | -96.0% | 158.1% | -1.29 | - |
| Sector ETF (XLB) | 18.2% | 17.7% | 0.78 | 13.3% |
| Equity (SPY) | 13.7% | 12.7% | 0.72 | 20.4% |
| Gold (GLD) | 1.8% | 28.3% | 0.05 | 28.1% |
| Commodities (DBC) | 48.4% | 20.6% | 1.80 | 0.8% |
| Real Estate (VNQ) | 2.8% | 13.9% | -0.05 | 6.7% |
| Bitcoin (BTCUSD) | -29.4% | 43.4% | -0.68 | 12.2% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with GRML | |
|---|---|---|---|---|
| GRML | -70.5% | 481.7% | 0.25 | - |
| Sector ETF (XLB) | 6.0% | 19.1% | 0.20 | 4.9% |
| Equity (SPY) | 12.7% | 17.1% | 0.56 | 4.6% |
| Gold (GLD) | 17.5% | 18.9% | 0.74 | 4.4% |
| Commodities (DBC) | 9.1% | 19.5% | 0.35 | 0.9% |
| Real Estate (VNQ) | 0.6% | 18.9% | -0.08 | 2.2% |
| Bitcoin (BTCUSD) | 4.1% | 51.6% | 0.26 | 8.6% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with GRML | |
|---|---|---|---|---|
| GRML | -45.6% | 481.7% | 0.25 | - |
| Sector ETF (XLB) | 10.4% | 20.7% | 0.44 | 4.9% |
| Equity (SPY) | 15.5% | 17.9% | 0.73 | 4.6% |
| Gold (GLD) | 12.0% | 16.4% | 0.60 | 4.4% |
| Commodities (DBC) | 8.2% | 18.1% | 0.37 | 0.9% |
| Real Estate (VNQ) | 5.0% | 20.7% | 0.20 | 2.2% |
| Bitcoin (BTCUSD) | 62.3% | 66.2% | 1.02 | 8.6% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Updated 6/3/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
Insider Activity
Updated 10/5/2026| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | El-Dada, Riad Hussein | Direct | Sell | 10052026 | 9.35 | 3,500 | Form | |||
| 2 | Leblanc, Jeff | Chief Financial Officer | Direct | Buy | 8252026 | 9.72 | 14,000 | 136,080 | 1,073,146 | Form |
| 3 | Sawyer, Jason David | Direct | Buy | 7232026 | 0.23 | 240,000 | 55,944 | 55,944 | Form | |
| 4 | McGarity, Jon | Direct | Buy | 7202026 | 0.18 | 140,000 | 24,822 | 97,741 | Form | |
| 5 | Leblanc, Jeff | Chief Financial Officer | Direct | Buy | 7172026 | 0.18 | 1,400,000 | 245,280 | 844,524 | Form |
| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | El-Dada, Riad Hussein | Direct | Sell | 10052026 | 9.35 | 3,500 | Form | |||
| 2 | Leblanc, Jeff | Chief Financial Officer | Direct | Buy | 8252026 | 9.72 | 14,000 | 136,080 | 1,073,146 | Form |
| 3 | Sawyer, Jason David | Direct | Buy | 7232026 | 0.23 | 240,000 | 55,944 | 55,944 | Form | |
| 4 | McGarity, Jon | Direct | Buy | 7202026 | 0.18 | 140,000 | 24,822 | 97,741 | Form | |
| 5 | Leblanc, Jeff | Chief Financial Officer | Direct | Buy | 7172026 | 0.18 | 1,400,000 | 245,280 | 844,524 | Form |
| 6 | El-Dada, Riad Hussein | Direct | Sell | 6252026 | 0.23 | 175,000 | 40,548 | 40,548 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.
Core Cache Last Updated: 10/28/2026